These findings indicate that post-stroke administration of L-4F may provide a potential strategy for neurorestoration following stroke injury in the T2DM population, and reducing neuroinflammation in the injured brain may contribute to the neurorestorative effects of L-4F at least partially independent of the ABCA1 signaling pathway. Here, ABCA1 is linked to type 2 diabetes mellitus.